October 17, 2025

Owens & Minor, Inc. (OMI) Investor Outlook: Evaluating a 36.89% Potential Upside Amidst Industry Challenges

Owens & Minor, Inc. (NYSE: OMI), a stalwart in the healthcare sector, finds itself navigating a complex landscape as it seeks to leverage its extensive experience..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: A Closer Look at Its Impressive Revenue Growth and Analyst Ratings

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is capturing the attention of investors with its compelling growth story within the healthcare sector. This commercial-stage biopharmaceutical company, specializing..

KalVista Pharmaceuticals (KALV) Stock Analysis: A Biotech Innovator with 187% Potential Upside

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is gaining investor attention with its impressive 187.84% potential upside, a figure that stands out in today’s volatile market environment. This..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Unveiling a 101.56% Potential Upside in the Biotech Space

For investors with a keen eye on the biotechnology sector, ArriVent BioPharma, Inc. (NASDAQ: AVBP) presents an intriguing opportunity. A clinical-stage company based in Newtown Square,..

STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth Challenges and Investment Potential

STAAR Surgical Company (NASDAQ: STAA) is a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Lake Forest, California,..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with Strategic Focus in the Medical Devices Sector

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector specializing in medical devices, is currently navigating a series of financial and operational challenges...

Nuvation Bio Inc. (NUVB) Stock Analysis: Unpacking the 124.98% Potential Upside in the Biotech Sphere

Nuvation Bio Inc. (NASDAQ: NUVB) is a name that has been capturing attention in the biotechnology sector, driven by its promising therapeutic pipeline and remarkable potential..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Exploring a Promising 16.14% Upside in the Biotech Arena

Sionna Therapeutics, Inc. (NASDAQ: SION) is capturing investor interest as it navigates the competitive and high-stakes world of biotechnology. Focused on developing innovative treatments for cystic..

Beta Bionics, Inc. (BBNX) Stock Analysis: Healthcare Innovator with a 22.8% Potential Upside

Beta Bionics, Inc. (NASDAQ: BBNX), a cutting-edge company in the healthcare sector, has captured investor attention with its innovative approach to managing diabetes and a notable..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Investor Outlook on a Potential 89.66% Upside

Enliven Therapeutics, Inc. (NASDAQ: ELVN) is garnering attention from investors as a promising player in the biotechnology sector, specifically within the field of cancer treatment. Headquartered..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Unpacking a Potential 306% Upside in the Biotech Sector

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) stands at an intriguing crossroads within the biotechnology sector, presenting a compelling case for investors with its substantial potential upside of..

Simulations Plus, Inc. (SLP) Stock Analysis: A 43.57% Potential Upside for Investors in Health Information Services

Simulations Plus, Inc. (NASDAQ: SLP) is capturing investor attention with its promising position in the healthcare sector, specifically within the health information services industry. With an..

Oculis Holding AG (OCS) Stock Analysis: Exploring a Potential 100% Upside in Biotech Innovation

Oculis Holding AG (OCS), a Swiss-based biopharmaceutical company, is making waves in the healthcare sector with its promising advancements in ophthalmic drug development. Positioned in the..

AnaptysBio, Inc. (ANAB): Investor Outlook on an 80.50% Potential Upside in the Biotech Sector

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company, has recently captured investor interest with its robust potential upside of 80.50%. Specializing in the development of innovative..

Savara, Inc. (SVRA) Stock Analysis: Exploring a 177% Potential Upside in the Biotech Space

Savara, Inc. (NASDAQ: SVRA), a promising player in the biotechnology sector, is capturing the attention of investors with its focus on addressing rare respiratory diseases. The..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: A Biotech Gem with a 93.79% Potential Upside

For investors eyeing opportunities in the biotechnology sector, Trevi Therapeutics, Inc. (NASDAQ: TRVI) presents an intriguing proposition. With an impressive potential upside of 93.79%, the company..

HealthStream, Inc. (HSTM) Stock Analysis: Unpacking a 29% Upside Potential

HealthStream, Inc. (HSTM) is a key player in the healthcare information services industry, leveraging its Software-as-a-Service (SaaS) platforms to support a range of healthcare organizations across..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: A 150% Potential Upside Fuels Investor Interest

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is capturing the attention of investors in the biotechnology sector, primarily due to its promising growth potential and impressive analyst ratings...

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Exploring an 85% Potential Upside in the Biotechnology Sector

Investors keeping a close watch on the healthcare and biotechnology sectors might find Arcus Biosciences, Inc. (NASDAQ: RCUS) an intriguing opportunity. With its impressive market cap..

Bicara Therapeutics Inc. (BCAX) Growth Potential: Analyst Ratings Signal 72% Upside

Bicara Therapeutics Inc. (BCAX) stands out in the biotechnology sector with a compelling potential upside of 72.07%, as indicated by the consensus of analyst ratings. Based..

Search

Funds

October 17, 2025

Search

Funds

October 17, 2025

FTSE 100

Funds